Heejae joined the Board as an Executive Director on 7 September 2009 and subsequently became Group Chief Executive in November 2009. Prior to joining Scapa, Heejae was Group Chief Executive of Volex Group plc. He spent the early part of his career in finance at The Blackstone Group and Credit Suisse First Boston before moving into industry. Heejae is currently a member of the Board of Overseers of the Boston Children's Hospital (BCH) and a Director of the BCH Foundation UK Ltd. Heejae was appointed as a Non-Executive Director of IP Group plc on 3 May 2018 and subsequently appointed as Remuneration Committee Chairman on 26 November 2019.

Oskar joined the Board as Chief Financial Officer on 1 October 2018. Prior to joining Scapa, Oskar was CFO at Spearhead International Ltd from 2008 to 2018. He was formerly a Vice President of Finance of EMEA for Teleflex Inc, Head of Finance for Engineering at British Airways Plc, European Group Controller for Georgia-Pacific Inc, and Audit Manager at KPMG. Oskar is a fellow of the Institute of Chartered Accountants England and Wales, and South Africa.

Chris joined the Board as Chairman on 7 August 2020. He is also Chairman of the Nomination Committee. Chris is currently Chairman of PeakData AG and Proveca Ltd as well as serving on Council at Imperial College where he chairs the finance committee. He is also a Non-Executive Director of OptiBiotix Health plc. Chris has worked on public and private boards as chair or NED for over a decade; he was most recently Chairman of Collagen Solutions plc and Consort Medical plc and Senior Independent Director of UDG Healthcare plc, and has worked in the global healthcare sector for over 40 years holding a number of senior executive and non-executive leadership positions.

David joined the Board on 1 May 2016 and was appointed Senior Independent Director on 17 July 2018. David is currently Chairman of the Audit and Risk Committee and is also a member of the Board's Remuneration and Nomination Committees. David is also currently Chairman of Connect Group PLC and Audit Chair and Senior Independent Director of Stobart Group PLC. He was previously Audit Chair and Senior Independent Director of Dignity Plc, and Group Finance Director of Synthomer plc. Prior to that, he was Group Treasurer at Imperial Chemical Industries plc and held a number of senior positions within ICI over a period of 22 years. David is a Chartered Accountant and a Fellow of the Association of Corporate Treasurers.

Brendan joined the Board on 1 February 2018 and is a member of the Board's Audit and Risk, Remuneration, and Nomination Committees. Brendan was appointed Chief Executive Officer of UDG Healthcare on 2 February 2016, having served as an Executive Director since December 2013, and having originally joined UDG as Chief Operating Officer in 2013. Prior to that, Brendan has held various senior management positions with Abbott, latterly as Vice President Commercial and Corporate Officer within its Established Pharmaceuticals Division.

Tim joined the Board on 20 January 2020 and is currently Chairman of the Remuneration Committee. Tim is also a Non-Executive Director and Remuneration Committee Chair of Clarkson plc, the world’s leading provider of integrated shipping services, and Equiniti Group plc, an international technology-led services and payments specialist. He is a Non-Executive Director of Otis Gold Corporation, a resource company listed on the Toronto Stock Exchange. The majority of Tim's executive career has been within regulated industries, including at Glaxo Wellcome and Standard Chartered, with global responsibility for areas including human resources, compliance, audit, assurance, financial crime, property and legal.

John Petreanu joined Scapa as President of Healthcare with effect from 4 May 2020. John was most recently Vice President Operations at Viant Medical, a US$1bn global services provider to the medical device industry. John was previously Chief Operating Officer for Scapa Healthcare, and has also held senior executive positions at Integer Holdings Corporation, Hospira, CareFusion (a subsidiary of BD), and Cardinal Health.

Wendy joined Scapa on 26 September 2017. Wendy is a solicitor with over 15 years’ experience as General Counsel and Company Secretary for multi-national, fully listed and AIM listed companies, including Volex Group plc, Promethean World plc and API Group plc. Wendy also qualified as an associate of the Chartered Insurance Institute prior to joining the legal profession.

Brett joined Scapa in September 2020. Brett has 20 years’ experience in the healthcare sector including roles in business and corporate development, corporate communications and equity research. Most recently he was head of Corporate Development and Investor Relations at Consort Medical plc (now part of Recipharm). Brett was previously a partner at FTI Consulting and before that COO and cofounder of Abingdon Health Ltd.